Laboratory Medicine ›› 2019, Vol. 34 ›› Issue (1): 84-85.DOI: 10.3969/j.issn.1673-8640.2019.01.018
Previous Articles Next Articles
Received:2018-07-03
Online:2019-01-30
Published:2019-01-29
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2019.01.018
| TP-IgM抗体 | 例数 | RPR滴度 | |||||
|---|---|---|---|---|---|---|---|
| 1∶2 | 1∶4 | 1∶8 | 1∶16 | 1∶32 | 1∶64 | ||
| 阴性 | 15 | 9 | 6 | 0 | 0 | 0 | 0 |
| 阳性 | 60 | 8 | 6 | 13 | 10 | 8 | 15 |
| TP-IgM抗体 | 例数 | RPR滴度 | |||||
|---|---|---|---|---|---|---|---|
| 1∶2 | 1∶4 | 1∶8 | 1∶16 | 1∶32 | 1∶64 | ||
| 阴性 | 15 | 9 | 6 | 0 | 0 | 0 | 0 |
| 阳性 | 60 | 8 | 6 | 13 | 10 | 8 | 15 |
| [1] | 王来栓,倪锦文,周文浩.先天性梅毒的流行病学和诊断治疗现状[J].中国循证儿科杂志 ,2010,5(1):64-70. |
| [2] | 王露楠,邓巍,李金明.梅毒螺旋体感染不同血清学诊断方法的临床评价[J].中华检验医学杂志,2002,25(6):352-353. |
| [3] | 何蒙文,刘欣欣,徐俊涛,等. 梅毒与妊娠[J]. 中国医学文摘(皮肤科学),2016,33(5):591-597. |
| [4] | 王临虹,王玲,王爱玲,等. 先天梅毒防治指南(一)[J]. 中国妇幼卫生杂志,2010,1(4):185-188. |
| [5] | 牟鸿江,王伟人,杨梅. 预防梅毒母婴传播效果评价指标探讨[J]. 中国艾滋病性病,2017,23(2):158-161. |
| [6] | 付金玲,曹玉忠,梁军. TP-IgM-WB法诊断早期先天梅毒的价值[J].海南医学,2015,26(5):682-683. |
| [7] | 曹谊,金一鸣,董丽,等. 免疫印迹法检测梅毒抗体及评价[J]. 中华医院感染学杂志,2011,21(24):5329-5330. |
| [8] | HERREMANS T,KORTBEEK L,NOTERMANS D W.A review of diagnostic tests for congenital syphilis in newborns[J]. Eur J Clin Microbiol Infect Dis,2010,29(5):495-501. |
| [1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
| [2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
| [3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
| [4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
| [5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
| [6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
| [7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
| [8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
| [9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
| [10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
| [11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
| [12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
| [13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
| [14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
| [15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
